The incidence and prevalence of delirium across palliative care settings: a systematic review

CL Watt, F Momoli, MT Ansari, L Sikora… - Palliative …, 2019 - journals.sagepub.com
Background: Delirium is a common and distressing neurocognitive condition that frequently
affects patients in palliative care settings and is often underdiagnosed. Aim: Expanding on a …

Clinical assessment and management of delirium in the palliative care setting

SH Bush, S Tierney, PG Lawlor - Drugs, 2017 - Springer
Delirium is a neurocognitive syndrome arising from acute global brain dysfunction, and is
prevalent in up to 42% of patients admitted to palliative care inpatient units. The symptoms of …

Delirium in the elderly: current problems with increasing geriatric age

D Kukreja, U Günther, J Popp - Indian Journal of Medical …, 2015 - journals.lww.com
Delirium is an acute disorder of attention and cognition seen relatively commonly in people
aged 65 yr or older. The prevalence is estimated to be between 11 and 42 per cent for …

Delirium in patients with cancer: assessment, impact, mechanisms and management

PG Lawlor, SH Bush - Nature Reviews Clinical Oncology, 2015 - nature.com
Delirium is a frequent neurocognitive complication in patients with cancer, particularly in
patients with advanced-stage disease (in whom a combination of factors might trigger an …

Drug therapy for delirium in terminally ill adults

AM Finucane, L Jones, B Leurent… - Cochrane Database …, 2020 - cochranelibrary.com
Background Delirium is a syndrome characterised by an acute disturbance of attention and
awareness which develops over a short time period and fluctuates in severity over the …

Medication use during end-of-life care in a palliative care centre

AD Masman, M van Dijk, D Tibboel, FPM Baar… - International journal of …, 2015 - Springer
Background In end-of-life care, symptoms of discomfort are mainly managed by drug
therapy, the guidelines for which are mainly based on expert opinions. A few papers have …

[HTML][HTML] End-of-life delirium: issues regarding recognition, optimal management, and the role of sedation in the dying phase

SH Bush, MM Leonard, M Agar, JA Spiller… - Journal of pain and …, 2014 - Elsevier
Context In end-of-life care, delirium is often not recognized and poses unique management
challenges, especially in the case of refractory delirium in the terminal phase. Objectives To …

Delirium diagnosis, screening and management

PG Lawlor, SH Bush - Current opinion in supportive and palliative …, 2014 - journals.lww.com
Although formal systematic delirium screening with brief but sensitive tools is strongly
advocated for patients in palliative and supportive care, it requires critical evaluation in terms …

Dexmedetomidine for hyperactive delirium at the end of life: an open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient …

B Thomas, WSA Lo, Z Nangati… - Palliative Medicine, 2021 - journals.sagepub.com
Background: Terminal delirium, specifically the hyperactive delirium subtype at the end of
life, is common in palliative care patients. Standard care often involves sedation to alleviate …

Delirium and agitation at the end of life

CMG Hosker, MI Bennett - bmj, 2016 - bmj.com
Delirium and agitation at the end of life | The BMJ Skip to main content Intended for healthcare
professionals Access provided by Google Indexer Subscribe My Account My email alerts BMA …